After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Teva- Pharmaceutical Industries Ltd. ADR is listed on the NYSE as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Teva- Pharmaceutical Industries Ltd. ADR is $21.73B. A total of 7.8 million shares were traded on the day, compared to an average of 11.19M shares.
In the most recent transaction, Jover Placid sold 6,053 shares of TEVA for 15.16 per share on Aug 01 ’25. After the transaction, the See “Remarks” now owns 6,774 company shares. In a previous transaction on Aug 01 ’25, Hughes Eric A sold 52,742 shares at 15.16 per share. TEVA shares that See “Remarks” owns now total 0.
Among the insiders who bought shares, Jover Placid acquired of 6,053 shares on Aug 01 ’25 at a per-share price of $15.16. In another insider transaction, Hughes Eric A bought 52,742 shares at $15.16 per share on Aug 01 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, TEVA has a high of $22.80 and a low of $12.47.
As of this writing, TEVA has an earnings estimate of $0.67 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of $0.71 per share and a lower estimate of $0.66. The company reported an EPS of $0.69 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TEVA’s latest balance sheet shows that the firm has $2.17B in Cash & Short Term Investments as of fiscal 2021. There were $23.46B in debt and $11.03B in liabilities at the time. Its Book Value Per Share was $5.95, while its Total Shareholder’s Equity was $11.24B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TEVA is Buy with a score of 4.80.
